Karyopharm Therapeutics Inc Congressional Trading
According to U.S. congressional financial disclosures filed under the STOCK Act, members of Congress have reported 1 trade in Karyopharm Therapeutics Inc (NASDAQ: KPTI) since 2025, across 1 member, worth an estimated $8.00K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts). Democratic members are responsible for 0% of the trades and Republican members 100%. These figures are drawn from public House and Senate periodic transaction reports and reflect what members were required to disclose, not the current market value of any position. For the full record, including the month-by-month buy and sell timeline, the party breakdown, top buyers and sellers, and every individual filing, see the Karyopharm Therapeutics Inc (KPTI) stock overview and the complete trade table below.
Price & congressional trade timeline
Party breakdown
Karyopharm Therapeutics congressional trading activity
| Politician | Published | Traded | Filed After | Type | Size | Return | |
|---|---|---|---|---|---|---|---|
| No congressional trades in this period. | |||||||
Karyopharm Therapeutics (KPTI) congressional trading FAQ
Can members of Congress legally trade Karyopharm Therapeutics (KPTI) stock?
Yes. Members of Congress are permitted to trade individual stocks, including Karyopharm Therapeutics (KPTI), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. BullishWhales tracks those disclosures; it does not imply any trade was improper.
Are congressional Karyopharm Therapeutics (KPTI) trades public?
Yes. Every congressional trade in Karyopharm Therapeutics (KPTI) on this page comes from mandatory public STOCK Act disclosure filings, which are filed with a delay and may be revised.
How many times has Congress traded Karyopharm Therapeutics (KPTI)?
Members of Congress have disclosed 1 trades in Karyopharm Therapeutics (KPTI) worth $8.00K across 1 members, according to public STOCK Act filings.
Do Democrats or Republicans trade Karyopharm Therapeutics (KPTI) more?
Across disclosed Karyopharm Therapeutics (KPTI) trades, 0% were by Democrats and 100% by Republicans, led by Republicans (100%).
Browse all stocks Congress tradesCongressional trading overviewKaryopharm Therapeutics (KPTI) stock overview
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. The Tide Score and other figures are generated algorithmically from public filings and market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.